Human immunodeficiency virus type 1 recombinant reverse transcriptase enzymes containing the G190A and Y181C resistance mutations remain sensitive to etravirine.
about
Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerabilityEffects of the W153L substitution in HIV reverse transcriptase on viral replication and drug resistance to multiple categories of reverse transcriptase inhibitors.Characterization of the E138K resistance mutation in HIV-1 reverse transcriptase conferring susceptibility to etravirine in B and non-B HIV-1 subtypes.Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitors.Compensation by the E138K mutation in HIV-1 reverse transcriptase for deficits in viral replication capacity and enzyme processivity associated with the M184I/V mutations.In vitro resistance profile of the candidate HIV-1 microbicide drug dapivirineAntiviral activity and in vitro mutation development pathways of MK-6186, a novel nonnucleoside reverse transcriptase inhibitorSubunit-selective mutational analysis and tissue culture evaluations of the interactions of the E138K and M184I mutations in HIV-1 reverse transcriptase.HIV-1 Antiretroviral Drug Resistance in Pregnant Women in Jamaica: A Preliminary ReportMolecular mechanism of antagonism between the Y181C and E138K mutations in HIV-1 reverse transcriptaseThe connection domain mutation N348I in HIV-1 reverse transcriptase enhances resistance to etravirine and rilpivirine but restricts the emergence of the E138K resistance mutation by diminishing viral replication capacity.In vitro characterization of MK-1439, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor.
P2860
Q24628212-90D97AF1-8713-49BF-BF2D-2102C9D7A5ECQ34058254-543252E4-4E06-4728-A758-0B2C11DD4077Q34529310-B2E92C25-0683-434D-90B7-8815358A4DD1Q35105844-4096B6E4-2FD6-4C35-8256-1C89DD4CE3FFQ35363054-194A41AE-2CE2-4213-B82D-3091B0384D6CQ35689311-3E319EC7-EB8A-4429-AA1A-5CA5E78CCE2BQ36018893-763CD48D-51ED-4BE0-B458-F59D8A7E4A10Q36172087-E44C9DC7-A7FA-4187-84FF-3884C5611189Q36330927-0959BA36-D004-4EA4-BE08-C5BB8B9EBE44Q36397384-E5A32B46-273C-49F4-ADE4-8AE534E23306Q37547275-9D112996-9646-4503-90F3-F1CA047D5913Q37643598-C12B636C-5175-4F60-A461-98D751813E20
P2860
Human immunodeficiency virus type 1 recombinant reverse transcriptase enzymes containing the G190A and Y181C resistance mutations remain sensitive to etravirine.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Human immunodeficiency virus t ...... emain sensitive to etravirine.
@en
Human immunodeficiency virus t ...... emain sensitive to etravirine.
@nl
type
label
Human immunodeficiency virus t ...... emain sensitive to etravirine.
@en
Human immunodeficiency virus t ...... emain sensitive to etravirine.
@nl
prefLabel
Human immunodeficiency virus t ...... emain sensitive to etravirine.
@en
Human immunodeficiency virus t ...... emain sensitive to etravirine.
@nl
P2093
P2860
P356
P1476
Human immunodeficiency virus t ...... remain sensitive to etravirine
@en
P2093
Bluma G Brenner
Hongtao Xu
Mark A Wainberg
Maureen Oliveira
Susan M Schader
Yudong Quan
P2860
P304
P356
10.1128/AAC.00800-09
P407
P577
2009-08-24T00:00:00Z